Symbol="MRUS"
AssetType="Common Stock"
Name="Merus BV"
Description="Merus NV, a clinical-stage immuno-oncology company, is dedicated to the discovery and development of bispecific antibody therapies in the Netherlands. The company is headquartered in Utrecht, the Netherlands."
CIK="1651311"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="YALELAAN 62, 3584 CM UTRECHT, NL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1323022000"
EBITDA="-168195008"
PERatio="None"
PEGRatio="0"
BookValue="4.694"
DividendPerShare="0"
DividendYield="0"
EPS="-3.49"
RevenuePerShareTTM="0.952"
ProfitMargin="0"
OperatingMarginTTM="-3.908"
ReturnOnAssetsTTM="-0.281"
ReturnOnEquityTTM="-0.591"
RevenueTTM="43430000"
GrossProfitTTM="-107838000"
DilutedEPSTTM="-3.49"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.158"
AnalystTargetPrice="45.7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="13.19"
PriceToBookRatio="2.148"
EVToRevenue="6.65"
EVToEBITDA="-2.372"
Beta="0.812"
num_52WeekHigh="30.81"
num_52WeekLow="12.03"
num_50DayMovingAverage="23.69"
num_200DayMovingAverage="19.35"
SharesOutstanding="49803200"
DividendDate="None"
ExDividendDate="None"
symbol="MRUS"
open="26.02"
high="27.21"
low="25.63"
price="27.15"
volume="381606.00"
latest_trading_day="2023-07-18"
previous_close="25.90"
change="1.25"
change_percent="4.8263%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="387722"
Change_recent_avg="0.04"
Delta_recent_avg="1.26"
Variance_recent_avg="0.63"
Change_ratio_recent_avg="0.08"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="1108"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0141.jpeg"
image_negative_thumbnail_id_2="1094"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0127.jpeg"
image_neutral_thumbnail_id_1="556"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_neutral_thumbnail_id_2="544"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_positive_thumbnail_id_1="686"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0022.jpeg"
image_positive_thumbnail_id_2="993"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
